GI cancers Flashcards
What is cancer?
- when abnormal cells divide without control and can invade nearby tissues
- cancer cells can also spread to other parts of the body through blood and lymph systems–> secondary/metastases
What is an adenocarcinoma?
type of cancer that starts in mucus-producing glandular cells e.g. in colon, lungs, breast
What is cancer screening and what are the Wilson&Jungner criteria?
testing asymptomatic individuals to identify cancer at an early stage
- the condition sought should be an important health problem
- there should be an accepted treatment for patients with recognised disease
- facilities for diagnosis and treatment should be available
- there should be a recognisable latent or early symptomatic stage
- there should be a suitable test or examination
- the test should be acceptable to the population
- the natural history of the condition, inc. development from latent to declared disease, should be adequately understood
What is the current screening program for colorectal cancer?
- offered to healthy individuals
- faecal immunochemical test (FIT): detects Hb in faeces- every 2 years for everyone aged 60-74
- one-off sigmoidoscopy for everyone aged >55–> if polyps present, they are removed (reduces risk of cancer)
What is the current screening program for oesophageal cancer?
regular endoscopy for patients with Barrett’s oesophagus or low - high grade dysplasia
What is the current screening program for pancreatic and gastric cancer?
- no test that meets W&J criteria
- depends on incidence- Japan screens for gastric cancer w/endoscopies
What is the current screening program for hepatocellular cancer?
regular ultrasound and AFP (alpha-fetoprotein) for high-risk individuals w/ cirrhosis: either due to viral hepatitis or alcoholic hepatitis (or NASH)
What is the 2-week wait cancer pathway?
within 2 weeks of presenting with worrying symptoms to GP or other, patient must have had diagnostic tests and been discussed in MDT meeting- and then offered treatment
What is molecular typing in pathology?
determines what mutatino the cancer has- can help to determine type of treatment
What is the difference between neoadjuvant and adjuvant chemotherapy?
neoadjuvant= chemo before surgery (to make tumour smaller and operable)
adjuvant= chemo after surgery (‘mopping up’)
What is the major driver of gastric adenocarcinoma?
chronic gastritis= major driver
- H. pylori infection–> causes inflammation of gastric mucosa–> gastritis, esp. in antrum of stomach–> duodenal ulcers–> inc. acid prod.–> metaplasia–> cancer
- pernicious anaemia–> autoantibodies against parts/products of parietal cells
- partial gastrectomy (e.g. for ulcer, before PPIs)–> bile reflux
- epstein-barr infection
- family history, inc. heritable diffuse-type gastric cancer due to E-cadherin mutations
- high salt diet and smoking
How do people with gastric cancer present and what are the red flags?
dyspepsia= commonest symptom (upper abdo discomfort after eating or drinking)
red flags- ALARMS55:
- Anaemia
- Loss of weight or appetite
- Abdominal mass on examination
- Recent onset of progressive symptoms
- Melaena (black, tarry stool) or haematemesis (vomiting blood)
- Swallowing difficulty
- 55 years or older
How do you diagnose gastric cancer?
endoscopy + biopsy
How do you stage gastric cancer?
- CT of chest, abdomen and pelvis - provides info on metastases
- PET-CT to pick up lesions you miss on CT scan
- diagnostic laparoscopy- to pick up peritoneal+ liver metastases before full op
- endoscopic US (backup) will give most detail about local invasion and node involvement
What are the treatment options for gastric cancer?
- neoadjuvant chemotherapy: to reduce tumour size before surgery
- for tumour at oesophago-gastric junction–> oesophago-gastrectomy- then join what’s left of stomach and oesophagus
- for tumour <5cm away from OG junction–> total gastrectomy, as you can’t save sphincter mechanism *
- for tumour >5cm away from OG junction–> subtotal gastrectomy, usual distal gastrectomy
- after successful gastric surgery- consider adjuvant chemotherapy in advanced tumours to reduce risk of relapse
- N.B. palliative approches: stenting or gastro-jejunal anastomosis if not possible to resect something